Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
Text
Arazlo™ (tazarotene) – New drug approval
December 19, 2019 - Bausch Health announced the FDA approval of Arazlo (tazarotene) lotion, for the topical treatment of acne vulgaris in patients 9 years of age and older..